FreeAgent 6fae3d5ded5e55babc717c15e8232559a7dd4dd4 false No description of principal activity 01 April 2025 31 March 2026 147233212025-04-012026-03-31 14723321uk-bus:Director12025-04-012026-03-31 14723321uk-bus:AuditExempt-NoAccountantsReport2025-04-012026-03-31 14723321uk-bus:Micro-entities2025-04-012026-03-31 14723321uk-bus:FullAccounts2025-04-012026-03-31 14723321uk-bus:PrivateLimitedCompanyLtd2025-04-012026-03-31 14723321uk-bus:RegisteredOfficeuk-countries:UnitedKingdom2025-04-012026-03-31 147233212025-04-01 147233212026-03-31 14723321uk-core:CurrentFinancialInstruments2026-03-31 14723321uk-core:Non-currentFinancialInstruments2026-03-31 147233212024-04-012025-03-31 147233212025-03-31 14723321uk-core:CurrentFinancialInstruments2025-03-31 14723321uk-core:Non-currentFinancialInstruments2025-03-31 iso4217:GBP xbrli:pure

Xr Anatomy Ltd

Unaudited financial statements for the year ended 31 March 2026


Company information

Xr Anatomy Ltd is a private company limited by shares, registered in England and Wales, registered number 14723321.

The company's registered office is: 71-75 Shelton Street, London, WC2H 9JQ, United Kingdom.

Balance Sheet

as at 31 March 2026

2026 2025
£ £
Fixed assets 0.00 40.16
Current assets 3,415.03 740.78
Creditors: amounts falling due within one year (2,215.93) (2,680.82)
Net current assets / (liabilities) 1,199.10 (1,940.04)
Total assets less current liabilities 1,199.10 (1,899.88)
Net assets 1,199.10 (1,899.88)
Capital and reserves 1,199.10 (1,899.88)

For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Directors' responsibilities:

Approved by the board of directors and signed on behalf of the board,

Bogdan Leahu
17 May 2026

Notes to the accounts

  1. Average number of employees

    During the year the average number of employees was 0 (2025: 0).

  2. Capital Commitments Note

    The company had no capital commitments at the year end.

  3. Contingent Liabilities Note

    The company had no contingent liabilities at the year end.

  4. Director Advances Credits Note

    During the year the company advanced £2,200 to a director. At 31 March 2026, £2,200 remained outstanding. No interest was charged. The loan is repayable on demand.

  5. Director Guarantees Note

    The company had not given any guarantees on behalf of directors at the year end.

  6. Financial Commitments Note

    The company had no financial commitments at the year end.